Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inferring Therapeutic Targets in Candida albicans and Possible Inhibition through Natural Products: A Binding and Physiological Based Pharmacokinetics Snapshot. | Life (Basel) | 2022 | 36362898 | PubTator, text mining | PubMed |
| Changes in CoQ10/Lipids Ratio, Oxidative Stress, and Coenzyme Q10 during First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma (mUC). | Int J Mol Sci | 2022 | 36361913 | PubTator, text mining | PubMed |
| Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. | Cells | 2022 | 36359888 | PubTator, text mining | PubMed |
| Intraoperative Optical Coherence Tomography in the Management of Macular Holes: State of the Art and Future Perspectives. | Biomedicines | 2022 | 36359392 | PubTator, text mining | PubMed |
| Atypical Substrates of the Organic Cation Transporter 1. | Biomolecules | 2022 | 36359014 | PubTator, text mining | PubMed |
| The Effect of Intraocular Pressure Load Boundary on the Biomechanics of the Human Conventional Aqueous Outflow Pathway. | Bioengineering (Basel) | 2022 | 36354583 | PubTator, text mining | PubMed |
| Correlation analysis between foveal avascular zone and near peripheral retinal hypoperfusion in multiple sclerosis: a wide field optical coherence tomography angiography study. | Front Med (Lausanne) | 2022 | 36353224 | PubTator, text mining | PubMed |
| An increase in Semaphorin 3A biases the axonal direction and induces an aberrant dendritic arborization in an in vitro model of human neural progenitor differentiation. | Cell Biosci | 2022 | 36348448 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Effects of lighting conditions and accommodation on the three-dimensional position of Visian implantable collamer lens. | Eye Vis (Lond) | 2022 | 36329521 | PubTator, text mining | PubMed |
| ESR1 dysfunction triggers neuroinflammation as a critical upstream causative factor of the Alzheimer's disease process. | Aging (Albany NY) | 2022 | 36326669 | PubTator, text mining | PubMed |
| Mechanisms governing target search and binding dynamics of hypoxia-inducible factors. | Elife | 2022 | 36322456 | PubTator, text mining | PubMed |
| Comparison of Central Corneal Thickness Measurements with Four Different New Devices and Ultrasound Pachymetry. | Turk J Ophthalmol | 2022 | 36317802 | PubTator, text mining | PubMed |
| Predicting attitudes towards screening for neurodegenerative diseases using OCT and artificial intelligence: Findings from a literature review. | J Public Health Res | 2022 | 36310821 | PubTator, text mining | PubMed |
| PRKCE non-coding variants influence on transcription as well as translation of its gene. | RNA Biol | 2022 | 36299231 | PubTator, text mining | PubMed |
| COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients. | Vaccines (Basel) | 2022 | 36298623 | PubTator, text mining | PubMed |
| Multiple Sclerosis Diagnosis Using Machine Learning and Deep Learning: Challenges and Opportunities. | Sensors (Basel) | 2022 | 36298206 | PubTator, text mining | PubMed |
| Personalized Medicine: Pharmacokinetics. | J Pers Med | 2022 | 36294799 | PubTator, text mining | PubMed |
| Benefits and Limitations of OCT-A in the Diagnosis and Follow-Up of Posterior Intraocular Inflammation in Current Clinical Practice: A Valuable Tool or a Deceiver? | Diagnostics (Basel) | 2022 | 36292075 | PubTator, text mining | PubMed |
| CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer. | Cancers (Basel) | 2022 | 36291875 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=41